Cargando…
m(6)A target microRNAs in serum for cancer detection
Recent studies have revealed the significant dysregulation of m(6)A level in peripheral blood in several cancer types and its value in diagnosis. Nonetheless, a biomarker for accurate screening of multiple cancer types has not been established based on the perspective of m(6)A modification. In this...
Autores principales: | Zhang, Bo, Chen, Zhenmei, Tao, Baorui, Yi, Chenhe, Lin, Zhifei, Li, Yitong, Shao, Weiqing, Lin, Jing, Chen, Jinhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686344/ https://www.ncbi.nlm.nih.gov/pubmed/34930277 http://dx.doi.org/10.1186/s12943-021-01477-6 |
Ejemplares similares
-
SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway: SREBP2 Inhibitor sensitizes HCC to lenvatinib
por: Fan, Minghao, et al.
Publicado: (2023) -
27‐Hydroxycholesterol promotes metastasis by SULT2A1‐dependent alteration in hepatocellular carcinoma
por: He, Taochen, et al.
Publicado: (2022) -
MicroRNAs expression profile in CCR6(+) regulatory T cells
por: Zhao, Juanjuan, et al.
Publicado: (2014) -
Serum microRNAs as biomarkers for recurrence in melanoma
por: Friedman, Erica B, et al.
Publicado: (2012) -
Data on microRNAs and microRNA-targeted mRNAs in Xenopus ectoderm
por: Shah, Vrutant V., et al.
Publicado: (2016)